Medlab Clinical Ltd Executes Master Services Agreement with WEP Clinical Ltd

Sydney, Australia – Medlab Clinical Ltd an Australian biotech using delivery platforms to enhance medicines is pleased to announce the execution of a Master Services Agreement with WEP Clinical Ltd for the exclusive development and delivery of Named Patient Programmes relating to the unlicensed supply of its proprietary NanaBis and NanoCBD to patients in the UK and Europe. This Master Services Agreement is the first …

Sydney, Australia (ABN Newswire) – Medlab Clinical Ltd (ASX.MDC), an Australian biotech using delivery platforms to enhance medicines is pleased to announce the execution of a Master Services Agreement (MSA) with WEP Clinical Ltd (WEP) for the exclusive development and delivery of Named Patient Programmes relating to the unlicensed supply of its proprietary NanaBis(TM) and NanoCBD(TM) to patients in the UK and Europe.

This Master Services Agreement is the first partnership for Medlab to supply their cannabinoid medications outside of its current Australian Special Access Scheme.

Dr Sean Hall, CEO of Medlab stated, “This is a major milestone for Medlab to begin supplying NanaBis(TM) and NanoCBD(TM) on prescription for the first time to patients outside Australia.”

Keep reading... Show less

Australia's Cannabis Export Market: Facts to Know

Australia's cannabis export market has been developing since the legalisation of medicinal marijuana. Here's what to know about the landscape.

The legalisation of medicinal cannabis in Australia, along with the decriminalisation of cannabis in the Australian Capital Territory, is creating opportunities for the export market.

But what types of cannabis products are being exported from Australia and where are they going?

Read on for a look at Australia's cannabis export market, including how it started up, where the country sends its cannabis products and what could be next as the nation's marijuana space develops.

Keep reading... Show less

Australian Cannabis Producers Could Play a Major Role Internationally

Australia's medical cannabis market is growing, but can it sustain the crop of companies currently involved in the space?

Australia's domestic medical cannabis market continues to gradually open, but is it big enough to sustain the country's plethora of producers?

As the industry gets more crowded, cannabis companies are looking at business options both at home and internationally as a way to increase their reach.

With ongoing questions surrounding the legalisation of cannabis for recreational purposes, Australia's advantageous placement may allow these firms to benefit from plays further afield.

Keep reading... Show less

What Investors Should Know About CBD in Australia

Interest in CBD in Australia is rising as the country's cannabis industry develops. What should investors know about this growing market?

Over the past five years, awareness about the medicinal properties of CBD has been growing. Although Australia's cannabis industry is still young, CBD hasn't escaped market watchers' attention.

CBD is a cannabidiol, meaning it is a compound found in the actual cannabis plant. It has steadily become a favourite in the development of novel products with various health uses. Part of its attraction stems from the fact that CBD lacks a heavy psychoactive nature, unlike its fellow molecule THC.

Although still in its infancy, research has shown CBD has anti-inflammatory properties, while offering the promise of more developed uses. It is gaining traction as a treatment for illnesses and conditions such as anxiety, post-traumatic stress disorder, depression, eating disorders, attention deficit hyperactivity disorder, migraines and some chronic pain disorders — to name just a few.

Keep reading... Show less
Cannabis Investing

Australian Company News

Market News

In exceptional market conditions, Rio Tinto achieves record financial results and declares total interim dividend of 561 US cents per share, 75% of underlying earnings

Rio Tinto Chief Executive Jakob Stausholm said “Government stimulus in response to ongoing COVID-19 pressures has driven strong demand for our products at a time of constrained supply resulting in a significant spike in most prices. We focused on safely running our world-class assets and supplying products to our customers. This enabled us, despite operational challenges, to deliver record financial results with …

Rio Tinto Chief Executive Jakob Stausholm said “Government stimulus in response to ongoing COVID-19 pressures has driven strong demand for our products at a time of constrained supply resulting in a significant spike in most prices. We focused on safely running our world-class assets and supplying products to our customers. This enabled us, despite operational challenges, to deliver record financial results with free cash flow of $10.2 billion and underlying earnings of $12.2 billion, after taxes and government royalties of $7.3 billion. We are further strengthening the portfolio with our commitment to fund the high-quality Jadar lithium project, which signals our large-scale entry into the fast-growing battery materials market. We will pay an interim dividend of 561 US cents per share, representing 75% of underlying earnings.

“We are making progress on our four priorities, identifying opportunities for operational improvement, advancing our ESG agenda, taking important investment decisions and stepping up our external engagement. We are making real and lasting changes to the way we engage, interact and operate and are committed to ensuring that we have strong and positive relationships wherever we do business. We have identified what we need to do to make Rio Tinto a better company for the long term, with the right teams in place to unleash our full potential.”

Keep reading... Show less

Classic Minerals Limited Quarterly Activities Report

Perth, Australia – Classic Minerals Limited has made significant progress at Kat Gap during the quarter as it strives to become a gold producer. Highlights of the quarter include: – Assay results returned for infill RC drilling testing the gap between oxide and deeper fresh rock high-grade gold mineralisation at Kat Gap. – Advancing engineering, mining and metallurgical studies at Kat Gap, and – IGO have made …

Perth, Australia (ABN Newswire) – Classic Minerals Limited (ASX:CLZ) has made significant progress at Kat Gap during the quarter as it strives to become a gold producer.

Highlights of the quarter include:

– Assay results returned for infill RC drilling testing the gap between oxide and deeper fresh rock high-grade gold mineralisation at Kat Gap.

Keep reading... Show less

STAY ON TOP OF INVESTING NEWS